+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RNAi Technology Market Size, Share & Trends Analysis Report by Product & Services (Products, Services), Application (Drug Discovery & Development, Functional Genomics), End Use and Region with Growth Forecasts, 2025-2033- Product Image
RNAi Technology Market Size, Share & Trends Analysis Report by Product & Services (Products, Services), Application (Drug Discovery & Development, Functional Genomics), End Use and Region with Growth Forecasts, 2025-2033- Product Image
New

RNAi Technology Market Size, Share & Trends Analysis Report by Product & Services (Products, Services), Application (Drug Discovery & Development, Functional Genomics), End Use and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 5983055
REQUEST CUSTOMIZATION
Description Jump to:
The global RNAi technology market size was estimated at USD 2.94 billion in 2024 and is projected to reach USD 9.52 billion by 2033, growing at a CAGR of 14.25% from 2025 to 2033. This market growth is attributed to the increasing prevalence of autoimmune diseases, rare disorders, and cancer across the globe.

Expansion of RNAi-Based Therapeutics

The RNAi technology market is growing rapidly due to strong clinical validation and multiple FDA/EMA approvals, including ONPATTRO, GIVLAARI, OXLUMO, and AMVUTTRA. These approvals have proven that RNAi can be developed into safe and effective therapeutics, boosting confidence among biopharma companies and accelerating investment in RNAi platforms. Its ability to precisely silence disease-causing genes makes RNAi a transformative option for rare genetic and liver-targeted disorders. As approved RNAi therapies show strong clinical and commercial performance, demand for RNAi tools, reagents, and delivery technologies continues to rise.

The growth of the market is being further accelerated by significant pharmaceutical interest. Through partnerships, acquisitions, and internal research and development, businesses such as Alnylam, Arrowhead, Dicerna (Novo Nordisk), AstraZeneca, and Takeda are growing their RNAi pipelines. Through these initiatives, RNAi applications are expanding into the fields of oncology, infectious diseases, and cardiometabolic disorders. Significant investments, enduring collaborations, and specialized RNAi research facilities are propelling clinical activity, product launches, and ongoing innovation. The need for RNAi platforms in drug discovery and clinical development keeps growing as the therapeutic pipeline broadens and industry investment increases.

Advancements in Delivery Technologies

Advances in RNAi delivery systems have become a key growth driver for the RNAi technology industry. Earlier issues, such as poor uptake, rapid degradation, and off-target effects, have been largely addressed through innovations in LNPs, GalNAc-siRNA conjugates, polymer carriers, and viral vectors. These next-generation platforms enhance stability, biodistribution, and tissue-specific targeting, particularly in the liver, a major site for genetic and metabolic disorders. As delivery becomes more efficient and clinically viable, demand for RNAi reagents, delivery kits, and development solutions continues to increase.

In addition, RNAi is expanding beyond liver targets owing to advanced delivery technologies. New strategies, such as targeted nanoparticles, peptide-based carriers, and engineered exosomes, are creating opportunities for applications in infectious diseases, cancer, and the central nervous system. To improve their pipelines and lower development risk, biopharma companies are making significant investments in these delivery innovations.

Global RNAi Technology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global RNAi technology market report on the basis of product & service, application, end use, and region:

Product & Service Outlook (Revenue, USD Million, 2021-2033)

  • Products
  • Service

Application Outlook (Revenue, USD Million, 2021-2033)

  • Drug Discovery & Development
  • Functional Genomics
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CROs & CMOs

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product & Service
1.2.2. Application
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expansion of RNAi-based therapeutics
3.2.1.2. Advancements in delivery technologies
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of skilled professionals and research support in developing countries
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. RNAi Technology Market: Product & Service Business Analysis
4.1. Product & Service Segment Dashboard
4.2. Global RNAi Technology Market Product & Service Movement Analysis
4.3. Global RNAi Technology Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Products
4.4.1. Global Products Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. miRNA
4.4.2.1. Global miRNA Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. siRNA
4.4.3.1. Global siRNA Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.4. Others
4.4.4.1. Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Services
4.5.1. Global Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. RNAi Technology Market: Application Business Analysis
5.1. Application Segment Dashboard
5.2. Global RNAi Technology Market Application, Movement Analysis
5.3. Global RNAi Technology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Drug Discovery & Development
5.4.1. Global Drug Discovery & Development Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.2. Neurology
5.4.2.1. Global Neurology Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.3. Oncology
5.4.3.1. Global Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.4. Infectious Diseases
5.4.4.1. Global Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.5. Metabolic Diseases
5.4.5.1. Global Metabolic Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.6. Others
5.4.6.1. Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Functional Genomics
5.5.1. Global Functional Genomics Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Others
5.6.1. Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. RNAi Technology Market: End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. Global RNAi Technology Market End Use Movement Analysis
6.3. Global RNAi Technology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. CROs & CMOs
6.6.1. Global CROs & CMOs Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. RNAi Technology Market: Regional Estimates & Trend Analysis by Product & Services, Application, & End Use
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
7.3. North America
7.3.1. North America RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4. Europe
7.4.1. Europe RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Denmark RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Asia-Pacific
7.5.1. Asia-Pacific RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. China RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Australia RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Thailand RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. South Korea RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Latin America
7.6.1. Latin America RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Argentina RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Middle East & Africa
7.7.1. Middle East & Africa RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Saudi Arabia RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. UAE RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait RNAi Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Participant’s Overview
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Creative Biolabs
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. GenScript
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Revvity
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Promega Corporation
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. OriGene Technologies, Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Altogen Biosystems
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Danaher
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Bioneer Corporation
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 4 Global RNAi technology market, by application, 2021-2033 (USD Million)
Table 5 Global RNAi technology market, by end use, 2021-2033 (USD Million)
Table 6 Global RNAi technology market, by region, 2021-2033 (USD Million)
Table 7 North America RNAi technology market, by country, 2021-2033 (USD Million)
Table 8 North America RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 9 North America RNAi technology market, by application, 2021-2033 (USD Million)
Table 10 North America RNAi technology market, by end use, 2021-2033 (USD Million)
Table 11 U.S. RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 12 U.S. RNAi technology market, by application, 2021-2033 (USD Million)
Table 13 U.S. RNAi technology market, by end use, 2021-2033 (USD Million)
Table 14 Canada RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 15 Canada RNAi technology market, by application, 2021-2033 (USD Million)
Table 16 Canada RNAi technology market, by end use, 2021-2033 (USD Million)
Table 17 Mexico RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 18 Mexico RNAi technology market, by application, 2021-2033 (USD Million)
Table 19 Mexico RNAi technology market, by end use, 2021-2033 (USD Million)
Table 20 Europe RNAi technology market, by country, 2021-2033 (USD Million)
Table 21 Europe RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 22 Europe RNAi technology market, by application, 2021-2033 (USD Million)
Table 23 Europe RNAi technology market, by end use, 2021-2033 (USD Million)
Table 24 UK RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 25 UK RNAi technology market, by application, 2021-2033 (USD Million)
Table 26 UK RNAi technology market, by end use, 2021-2033 (USD Million)
Table 27 Germany RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 28 Germany RNAi technology market, by application, 2021-2033 (USD Million)
Table 29 Germany RNAi technology market, by end use, 2021-2033 (USD Million)
Table 30 France RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 31 France RNAi technology market, by application, 2021-2033 (USD Million)
Table 32 France RNAi technology market, by end use, 2021-2033 (USD Million)
Table 33 Italy RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 34 Italy RNAi technology market, by application, 2021-2033 (USD Million)
Table 35 Italy RNAi technology market, by end use, 2021-2033 (USD Million)
Table 36 Spain RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 37 Spain RNAi technology market, by application, 2021-2033 (USD Million)
Table 38 Spain RNAi technology market, by end use, 2021-2033 (USD Million)
Table 39 Denmark RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 40 Denmark RNAi technology market, by application, 2021-2033 (USD Million)
Table 41 Denmark RNAi technology market, by end use, 2021-2033 (USD Million)
Table 42 Sweden RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 43 Sweden RNAi technology market, by application, 2021-2033 (USD Million)
Table 44 Sweden RNAi technology market, by end use, 2021-2033 (USD Million)
Table 45 Norway RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 46 Norway RNAi technology market, by application, 2021-2033 (USD Million)
Table 47 Norway RNAi technology market, by end use, 2021-2033 (USD Million)
Table 48 Asia-Pacific RNAi technology market, by country, 2021-2033 (USD Million)
Table 49 Asia-Pacific RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 50 Asia-Pacific RNAi technology market, by application, 2021-2033 (USD Million)
Table 51 Asia-Pacific RNAi technology market, by end use, 2021-2033 (USD Million)
Table 52 Japan RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 53 Japan RNAi technology market, by application, 2021-2033 (USD Million)
Table 54 Japan RNAi technology market, by end use, 2021-2033 (USD Million)
Table 55 China RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 56 China RNAi technology market, by application, 2021-2033 (USD Million)
Table 57 China RNAi technology market, by end use, 2021-2033 (USD Million)
Table 58 India RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 59 India RNAi technology market, by application, 2021-2033 (USD Million)
Table 60 India RNAi technology market, by end use, 2021-2033 (USD Million)
Table 61 Australia RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 62 Australia RNAi technology market, by application, 2021-2033 (USD Million)
Table 63 Australia RNAi technology market, by end use, 2021-2033 (USD Million)
Table 64 Thailand RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 65 Thailand RNAi technology market, by application, 2021-2033 (USD Million)
Table 66 Thailand RNAi technology market, by end use, 2021-2033 (USD Million)
Table 67 South Korea RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 68 South Korea RNAi technology market, by application, 2021-2033 (USD Million)
Table 69 South Korea RNAi technology market, by end use, 2021-2033 (USD Million)
Table 70 Latin America RNAi technology market, by country, 2021-2033 (USD Million)
Table 71 Latin America RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 72 Latin America RNAi technology market, by application, 2021-2033 (USD Million)
Table 73 Latin America RNAi technology market, by end use, 2021-2033 (USD Million)
Table 74 Brazil RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 75 Brazil RNAi technology market, by application, 2021-2033 (USD Million)
Table 76 Brazil RNAi technology market, by end use, 2021-2033 (USD Million)
Table 77 Argentina RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 78 Argentina RNAi technology market, by application, 2021-2033 (USD Million)
Table 79 Argentina RNAi technology market, by end use, 2021-2033 (USD Million)
Table 80 Middle East & Africa RNAi technology market, by country, 2021-2033 (USD Million)
Table 81 Middle East & Africa RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 82 Middle East & Africa RNAi technology market, by application, 2021-2033 (USD Million)
Table 83 Middle East & Africa RNAi technology market, by end use, 2021-2033 (USD Million)
Table 84 South Africa RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 85 South Africa RNAi technology market, by application, 2021-2033 (USD Million)
Table 86 South Africa RNAi technology market, by end use, 2021-2033 (USD Million)
Table 87 Saudi Arabia RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 88 Saudi Arabia RNAi technology market, by application, 2021-2033 (USD Million)
Table 89 Saudi Arabia RNAi technology market, by end use, 2021-2033 (USD Million)
Table 90 UAE RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 91 UAE RNAi technology market, by application, 2021-2033 (USD Million)
Table 92 UAE RNAi technology market, by end use, 2021-2033 (USD Million)
Table 93 Kuwait RNAi technology market, by product & service, 2021-2033 (USD Million)
Table 94 Kuwait RNAi technology market, by application, 2021-2033 (USD Million)
Table 95 Kuwait RNAi technology market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 RNAi technology market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Parent market outlook
Figure 11 RNAi technology market driver analysis
Figure 12 RNAi technology market restraint analysis
Figure 13 RNAi technology market: Porter's analysis
Figure 14 RNAi technology market: PESTEL analysis
Figure 15 RNAi technology market: Product & Service outlook and key takeaways
Figure 16 RNAi technology market: Product & Service market share analysis
Figure 17 Global RNAi technology by products market, 2021-2033 (USD Million)
Figure 18 Global RNAi technology by miRNA market, 2021-2033 (USD Million)
Figure 19 Global RNAi technology by siRNA market, 2021-2033 (USD Million)
Figure 20 Global RNAi technology by others market, 2021-2033 (USD Million)
Figure 21 Global RNAi technology by service market, 2021-2033 (USD Million)
Figure 22 RNAi technology market: Application outlook and key takeaways
Figure 23 RNAi technology market: Application market share analysis
Figure 24 Global RNAi technology by drug discovery & development market, 2021-2033 (USD Million)
Figure 25 Global RNAi technology by neurology market, 2021-2033 (USD Million)
Figure 26 Global RNAi technology by oncology market, 2021-2033 (USD Million)
Figure 27 Global RNAi technology by infectious diseases market, 2021-2033 (USD Million)
Figure 28 Global RNAi technology by metabolic diseases market, 2021-2033 (USD Million)
Figure 29 Global RNAi technology by others market, 2021-2033 (USD Million)
Figure 30 Global RNAi technology by functional genomics market, 2021-2033 (USD Million)
Figure 31 Global RNAi technology others market, 2021-2033 (USD Million)
Figure 32 RNAi technology market: End Use outlook and key takeaways
Figure 33 RNAi technology market: End Use market share analysis
Figure 34 Global RNAi technology by pharmaceutical & biotechnology companies market, 2021-2033 (USD Million)
Figure 35 Global RNAi technology by academic & research institutes market, 2021-2033 (USD Million)
Figure 36 Global RNAi technology by CROs & CMOs market, 2021-2033 (USD Million)
Figure 37 Regional marketplace: Key takeaways
Figure 38 North America RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 39 U.S. RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 40 Canada RNAi technology market, 2021-2033 (USD Million)
Figure 41 Mexico RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 42 Europe RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 43 UK RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 44 Germany RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 45 France RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 46 Italy RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 47 Spain RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 48 Denmark RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 49 Sweden RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 50 Norway RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 51 Asia-Pacific RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 52 Japan RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 53 China RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 54 India RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 55 Australia RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 56 Thailand RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 57 South Korea RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 58 Latin America RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 59 Brazil RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 60 Argentina RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 61 Middle East & Africa RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 62 South Africa RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 63 Saudi Arabia RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 64 UAE RNAi technology market estimates and forecast, 2021-2033 (USD Million)
Figure 65 Kuwait RNAi technology market estimates and forecast, 2021-2033 (USD Million)

Companies Mentioned

The key companies profiled in this RNAi Technology market report include:
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Creative Biolabs
  • GenScript
  • Revvity
  • Promega Corporation
  • OriGene Technologies, Inc.
  • Altogen Biosystems
  • Danaher
  • Bioneer Corporation

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 2.94 Billion
Forecasted Market Value ( USD ) by 2033 $ 9.52 Billion
Compound Annual Growth Rate14.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

RNAi Therapeutics Market - Global Forecast 2025-2030 - Product Image

RNAi Therapeutics Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
RNAi Technology Market - Global Strategic Business Report - Product Image

RNAi Technology Market - Global Strategic Business Report

  • Report
  • 138 Pages
  • Global
From
Antisense & RNAi Therapeutics Market Report by Technology, Route of Administration, Application, and Region 2025-2033 - Product Image

Antisense & RNAi Therapeutics Market Report by Technology, Route of Administration, Application, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
RNA Interference Drug Delivery Market Report by Application, Technology, and Region 2025-2033 - Product Image

RNA Interference Drug Delivery Market Report by Application, Technology, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
RNA Interference (RNAi) - Global Strategic Business Report - Product Image

RNA Interference (RNAi) - Global Strategic Business Report

  • Report
  • 178 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.